"10.1371_journal.pone.0102987","plos one","2014-07-24T00:00:00Z","Chris Newby; Liam G Heaney; Andrew Menzies-Gow; Rob M Niven; Adel Mansur; Christine Bucknall; Rekha Chaudhuri; John Thompson; Paul Burton; Chris Brightling; on behalf of the British Thoracic Society Severe Refractory Asthma Network","Department of Infection, Inflammation and Immunity, Institute for Lung Health, University of Leicester, Leicester, United Kingdom; Department of Health Sciences, University of Leicester, Leicester, United Kingdom; Centre for Infection and Immunity, Queen's University of Belfast, Belfast, United Kingdom; Royal Brompton Hospital, London, United Kingdom; North West Lung Centre, University of Manchester, Manchester, United Kingdom; Severe and Brittle Asthma Unit, Birmingham Heartlands Hospital, Birmingham, United Kingdom; Department of Respiratory Medicine, Stobhill Hospital, Glasgow, United Kingdom; Department of Respiratory Medicine, Division of Immunology, Infection and Inflammation, University of Glasgow and Gartnavel General, Glasgow, United Kingdom","Conceived and designed the experiments: CN C. Brightling PB JT LH. Analyzed the data: CN. Wrote the paper: CN C. Brightling. Contribution of data: LH AM-G RMN AM C. Bucknall RC C. Brightling. Editing manuscript: CN LH AM-G RMN AM C. Bucknall RC C. Brightling.","Pilot funding for the Registry was provided as unrestricted research grants from Astra Zeneca, Glaxo Smith Kline and Novartis. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","07","Chris Newby","CN",11,TRUE,2,NA,1,2,TRUE,TRUE,TRUE,3,"8;9;11",TRUE
